Alexandra Sokolova

846 total citations
42 papers, 438 citations indexed

About

Alexandra Sokolova is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Alexandra Sokolova has authored 42 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Alexandra Sokolova's work include Prostate Cancer Treatment and Research (28 papers), PARP inhibition in cancer therapy (10 papers) and Cancer Genomics and Diagnostics (7 papers). Alexandra Sokolova is often cited by papers focused on Prostate Cancer Treatment and Research (28 papers), PARP inhibition in cancer therapy (10 papers) and Cancer Genomics and Diagnostics (7 papers). Alexandra Sokolova collaborates with scholars based in United States, Canada and Spain. Alexandra Sokolova's co-authors include Heather H. Cheng, Michael T. Schweizer, Celestia S. Higano, Eric J. Small, Edward M. Schaeffer, Emmanuel S. Antonarakis, Catherine H. Marshall, Alan H. Bryce, Andrea McNatty and Mario A. Eisenberger and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and CHEST Journal.

In The Last Decade

Alexandra Sokolova

30 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandra Sokolova United States 9 310 229 149 138 62 42 438
Gillianne Lai Singapore 5 197 0.6× 190 0.8× 106 0.7× 122 0.9× 70 1.1× 18 374
Amelie Lier Germany 8 208 0.7× 288 1.3× 238 1.6× 130 0.9× 78 1.3× 9 467
Eirini Thanopoulou United Kingdom 12 158 0.5× 148 0.6× 113 0.8× 121 0.9× 28 0.5× 26 401
Samuel Suzuki United States 9 130 0.4× 228 1.0× 102 0.7× 214 1.6× 65 1.0× 22 460
Sarah Abou Alaiwi United States 12 207 0.7× 238 1.0× 92 0.6× 127 0.9× 51 0.8× 44 428
Julie Niolat France 8 166 0.5× 149 0.7× 91 0.6× 199 1.4× 28 0.5× 13 488
HS Rugo United States 13 199 0.6× 459 2.0× 189 1.3× 105 0.8× 25 0.4× 49 561
T.M. Kim South Korea 7 152 0.5× 266 1.2× 86 0.6× 127 0.9× 134 2.2× 14 416
Danmei Pang China 7 151 0.5× 196 0.9× 113 0.8× 117 0.8× 43 0.7× 17 357
A. Valent France 10 125 0.4× 155 0.7× 89 0.6× 101 0.7× 52 0.8× 18 318

Countries citing papers authored by Alexandra Sokolova

Since Specialization
Citations

This map shows the geographic impact of Alexandra Sokolova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Sokolova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Sokolova more than expected).

Fields of papers citing papers by Alexandra Sokolova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Sokolova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Sokolova. The network helps show where Alexandra Sokolova may publish in the future.

Co-authorship network of co-authors of Alexandra Sokolova

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Sokolova. A scholar is included among the top collaborators of Alexandra Sokolova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Sokolova. Alexandra Sokolova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tran, Ben, Kevin D. Courtney, Alexandra Sokolova, et al.. (2025). A phase 1b, open-label, multicenter study of xaluritamig in patients with biochemical recurrence of prostate cancer after definitive therapy.. Journal of Clinical Oncology. 43(5_suppl).
2.
Winters‐Stone, Kerri M., Sydnee Stoyles, Nathan F. Dieckmann, et al.. (2025). Suffering in Silence: Loneliness Among Men with Prostate Cancer and the Potential for Exercise as Connection. European Urology Oncology. 8(3). 792–795.
3.
Sokolova, Alexandra, Catherine M. Tangen, Maha Hussain, et al.. (2025). Evaluating survival post-7 mo PSA response, stratified by response, disease extent, and intermittent vs. continuous ADT in mHSPC: The S9346 trial.. Journal of Clinical Oncology. 43(5_suppl). 268–268. 1 indexed citations
4.
Ong, Michael, Rana R. McKay, Catherine M. Tangen, et al.. (2025). Approach to treatment of metastatic hormone-sensitive prostate (mHSPC) cancer among cooperative oncology groups (CCTG, SWOG, and Alliance) in North America.. Journal of Clinical Oncology. 43(5_suppl). 263–263.
5.
Thapa, Bibhusal, Clara Hwang, Alexandra Sokolova, et al.. (2024). 1643P Impact of PTEN alterations on clinical outcomes in patients (pts) with de novo metastatic prostate cancer (mPC). Annals of Oncology. 35. S991–S991.
6.
Cheng, Heather H., Daniel J. Lee, Michael A. Liss, et al.. (2024). Prostate screening for men with inherited risk of developing aggressive prostate cancer: The PATROL study.. Journal of Clinical Oncology. 42(4_suppl). TPS357–TPS357.
7.
Winters‐Stone, Kerri M., Sydnee Stoyles, Nathan F. Dieckmann, et al.. (2024). POTENTIAL BENEFITS OF GROUP EXERCISE ON CANCER-RELATED LONELINESS AMONG MEN ENROLLED IN THE GET FIT PROSTATE TRIAL. Innovation in Aging. 8(Supplement_1). 709–709.
8.
Yılmaz, Burçak, et al.. (2024). Genetic analysis of metastatic castration resistant prostate cancer patients treated with Lu-177 PSMA radioligand therapy.. Journal of Clinical Oncology. 42(16_suppl). e17063–e17063. 1 indexed citations
9.
Vaishampayan, Ulka N., Deepak Kilari, Tanya B. Dorff, et al.. (2024). 1600P Phase II trial of pembrolizumab and lenvatinib in advanced neuroendocrine prostate cancer (NEPC). Annals of Oncology. 35. S965–S965.
10.
Andeen, Nicole K., et al.. (2024). Mixed Adenosquamous Cell Carcinoma of the Prostate with Paired Sequencing on the Primary and Liver Metastasis. Current Oncology. 31(5). 2393–2399.
11.
Sokolova, Alexandra, et al.. (2024). Germline and somatic mutations in prostate cancer: Implications for treatment. Current Problems in Cancer. 50. 101101–101101. 1 indexed citations
12.
Yılmaz, Burçak, et al.. (2024). Use of PSMA PET/CT to detect prostate cancer metastatic to a preexisting thyroid nodule. npj Precision Oncology. 8(1). 132–132.
13.
Sokolova, Alexandra, et al.. (2024). Prostate cancer and genetic contributions. Andrology. 13(5). 1149–1157.
14.
Sokolova, Alexandra. (2021). Germline Testing in Prostate Cancer: When and Who to Test. 645–653. 9 indexed citations
15.
Sokolova, Alexandra, Elias Obeid, & Heather H. Cheng. (2021). Genetic Contribution to Metastatic Prostate Cancer. Urologic Clinics of North America. 48(3). 349–363. 2 indexed citations
16.
Graham, Laura, Alexandra Sokolova, Ali Raza Khaki, Qian Wu, & Nancy E. Davidson. (2020). Gender Differences in Faculty Rank and Subspecialty Choice among Academic Medical Oncologists. Cancer Investigation. 39(1). 21–24. 2 indexed citations
17.
Sokolova, Alexandra & Heather H. Cheng. (2020). Genetic Testing in Prostate Cancer. Current Oncology Reports. 22(1). 5–5. 27 indexed citations
18.
Sokolova, Alexandra, Brian H. Shirts, Eric Q. Konnick, et al.. (2020). Complexities of Next-Generation Sequencing in Solid Tumors: Case Studies. Journal of the National Comprehensive Cancer Network. 18(9). 1150–1155. 3 indexed citations
19.
Marshall, Catherine H., Alexandra Sokolova, Andrea McNatty, et al.. (2019). Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations. European Urology. 76(4). 452–458. 109 indexed citations
20.
Sokolova, Alexandra, et al.. (2017). Hereditary persistence of hemoglobin F is protective against red cell sickling. A case report and brief review. Hematology/Oncology and Stem Cell Therapy. 12(4). 215–219. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gillianne Lai Breakdown of academic impact, for papers by Amelie Lier Breakdown of academic impact, for papers by Eirini Thanopoulou Breakdown of academic impact, for papers by Samuel Suzuki Breakdown of academic impact, for papers by Sarah Abou Alaiwi Breakdown of academic impact, for papers by Julie Niolat Breakdown of academic impact, for papers by HS Rugo Breakdown of academic impact, for papers by T.M. Kim Breakdown of academic impact, for papers by Danmei Pang Breakdown of academic impact, for papers by A. Valent
Rankless by CCL
2026